Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

被引:48
|
作者
Blaser, J
Triebel, S
Maasjosthusmann, U
Romisch, J
KrahlMateblowski, U
Freudenberg, W
Fricke, R
Tschesche, H
机构
[1] UNIV BIELEFELD,INST BIOCHEM,D-33615 BIELEFELD,GERMANY
[2] ST JOSEFS STIFT SENDENHORST,KLIN RHEUMATOL,BIELEFELD,GERMANY
[3] BEHRINGWERKE AG,RES LABS,W-3550 MARBURG,GERMANY
关键词
metalloproteinases; urokinase-plasminogen-activator; rheumatoid arthritis; synoviorthesis;
D O I
10.1016/0009-8981(95)06172-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The concentrations of matrix metalloproteinase-l (MMP-1), matrix metalloproteinase-8 (MMP-8), matrix metalloproteinase-9 (MMP-8), lactoferrin and urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA) and the inhibitors, tissue inhibitor of metalloproteinase-l (TIMP-1), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor (PAI-2), and alpha(2)-macroglobulin in the synovial fluids of patients with rheumatoid arthritis was determined before and during chemical synoviorthesis with a sodium salt of the fatty acids from cod-liver oil (Varicocid). synovial fluids were obtained before treatment from 37 patients with rheumatoid arthritis and, in most cases, at 8 and 24 h after injection of the agent. Well-established ELISAs were used to determine the amounts of all proteins. All patients with rheumatoid arthritis revealed very high levels of metalloproteinases (about 1-15 mu g/ml) in their synovial fluids. During the inflammation inducing treatment the granulocyte enzymes increased. In contrast to this, the level of MMP-1 decreased. All granulocyte-derived enzymes were strongly correlated with each other, whereas their dependence on the granulocyte count was only weak. uPA and PAI-2 showed good correlations with the granulocytes-derived enzymes, but were also only weakly correlating with the cell counts. tPA was not detected by the ELISA used. The proteases, MMP-8, MMP9 and uPA were increased 8 h after the treatment, whereas the specific inhibitors TIMP-1, PAI-1 and PAI-2 showed significant changes only 24 h after the injection. Matrix metalloproteinases are important factors in the pathogenesis of rheumatoid arthritis. The inflammatory activity in the joint could be better correlated to the granulocyte enzymes than to the granulocyte counts. The levels of uPA and PA1-2 are also parallel to the granulocyte enzyme levels and might underly the same regulatory mechanism.
引用
收藏
页码:17 / 33
页数:17
相关论文
共 50 条
  • [31] SEARCH FOR MYCOPLASMA IN SYNOVIAL-FLUIDS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS
    WINDSOR, GD
    NICHOLLS, A
    EDWARD, DGF
    LEMCKE, RM
    DUMONDE, DC
    MAINI, RN
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1974, 33 (01) : 70 - 74
  • [32] BLYS EXPRESSION IN SYNOVIAL FLUIDS FROM RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE
    Mas, Luciana
    Retamozo, Soledad
    Saurit, Veroica
    Ceballos Recalde, Maria Flavia
    Pablo Pirola, Juan
    Haye Salinas, Maria Jezabel
    Caeiro, Francisco
    Raquel Benzaquen, Nadia
    Alvarellos, Alejandro
    Alvarellos, Teresita
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 134 - 135
  • [33] Comparative Proteomic Analyses of Synovial Fluids and Serums from Rheumatoid Arthritis Patients
    Noh, Ran
    Park, Sung Goo
    Ju, Ji Hyeon
    Chi, Seung-Wook
    Kim, Sunhong
    Lee, Chong-Kil
    Kim, Jeong-Hoon
    Park, Byoung Chul
    [J]. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2014, 24 (01) : 119 - 126
  • [34] ELEVATIONS IN SYNOVIAL-FLUID PLASMINOGEN-ACTIVATOR IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    MOCHAN, E
    UHL, J
    [J]. JOURNAL OF RHEUMATOLOGY, 1984, 11 (02) : 123 - 128
  • [35] Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis
    Ronday, HK
    Smits, HH
    VanMuijen, GNP
    Pruszczynski, MSM
    Dolhain, RJEM
    VanLangelaan, EJ
    Breedveld, FC
    Verheijen, JH
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (05): : 416 - 423
  • [36] Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis
    Klimiuk, PA
    Sierakowski, S
    Domyslawska, I
    Chwiecko, J
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (02) : 238 - 242
  • [37] PLASMINOGEN-ACTIVATOR IN SYNOVIAL-FLUID FROM PATIENTS WITH RHEUMATOID-ARTHRITIS
    KIKUCHI, H
    TANAKA, S
    MATSUO, O
    [J]. JOURNAL OF RHEUMATOLOGY, 1987, 14 (03) : 439 - 445
  • [38] Molecular abnormalities of human plasminogen isolated from synovial fluid of rheumatoid arthritis patients
    Shearin, TV
    Pizzo, SV
    GonzalezGronow, M
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (05): : 378 - 385
  • [39] High Adiponectin and Adiponectin Receptor 1 Expression in Synovial Fluids and Synovial Tissues of Patients with Rheumatoid Arthritis
    Tan, Wenfeng
    Wang, Fang
    Zhang, Miaojia
    Guo, Dunming
    Zhang, Qiande
    He, Shaoheng
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 38 (06) : 420 - 427
  • [40] THE MEASUREMENT OF COLLAGENASE, TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP), AND COLLAGENASE TIMP COMPLEX IN SYNOVIAL-FLUIDS FROM PATIENTS WITH OSTEOARTHRITIS AND RHEUMATOID-ARTHRITIS
    CLARK, IM
    POWELL, LK
    RAMSEY, S
    HAZLEMAN, BL
    CAWSTON, TE
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 372 - 379